Strategy Plans to Sell Bitcoin Back to Fund Buybacks
Strategy disclosed a program to sell bitcoin from time to time to support its USD reserve and finance stock repurchas...
When To Choose Index Funds Over Bonds
Index funds and bonds serve different roles in a diversified portfolio. This guide explains when index funds may be preferred over bonds and how to balance exposure.
25,248 articles
Trump’s Billion Smart Wall Bets on AI and Scale for 2026
A $46 billion smart wall project along the U.S.-Mexico border accelerates, blending a tall fence with AI-powered sens...
Trump Rings Opening Bell as Trump Accounts Seed Money Flows
A historic White House ceremony tied a market milestone to a child-focused investing program. Treasury confirms $1.4 ...
Office Conversions Face Scrutiny After Pfizer HQ Incident
A buckling-column episode at the former Pfizer headquarters triggers renewed scrutiny of NYC office-to-residential pr...
Olivia Attwood’s Savano Cocktail: A Seven-Figure Deal
Celebrity branding can turn a sip into serious money. This article dives into Olivia Attwood’s Savano cocktail and wh...
Stock Market Giving Pristine Entry to 64-Year Dividend King
As stocks edge higher in mid-2026, a 64-year dividend king stands out as a pristine entry point for income-focused in...
Bitcoin Slides Toward $63,000 as Coinbase Premium Drops
Bitcoin slides toward $63,000 as a broad market pullback and a record-long negative Coinbase premium weigh on prices....
Crypto Industry Spent Nearly $200M: What Investors Need
A flood of political spending from crypto firms aimed at shaping new laws has investors eyeing policy risk. This guid...
Power Dynamic Taken Hold Reshapes Real Estate Loans
A shift is sweeping real estate finance: lenders are resetting terms, buyers are adjusting plans, and landlords are l...
Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Here's Grail Stock Bounced: Why the Rebound Today
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...
Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status